BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23176534)

  • 1. Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.
    Venza I; Visalli M; Oteri R; Cucinotta M; Teti D; Venza M
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):193-204. PubMed ID: 23176534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
    Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
    FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2.
    Yamaguchi K; Lantowski A; Dannenberg AJ; Subbaramaiah K
    J Biol Chem; 2005 Sep; 280(38):32569-77. PubMed ID: 15994313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
    Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW
    Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence.
    Moschos MM; Dettoraki M; Androudi S; Kalogeropoulos D; Lavaris A; Garmpis N; Damaskos C; Garmpi A; Tsatsos M
    Anticancer Res; 2018 Jul; 38(7):3817-3824. PubMed ID: 29970501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
    Koppel I; Timmusk T
    Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific activity of class II histone deacetylases in human breast cancer cells.
    Duong V; Bret C; Altucci L; Mai A; Duraffourd C; Loubersac J; Harmand PO; Bonnet S; Valente S; Maudelonde T; Cavailles V; Boulle N
    Mol Cancer Res; 2008 Dec; 6(12):1908-19. PubMed ID: 19074835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.
    Sharma P; Kumar S; Kundu GC
    Mol Cancer; 2010 Jul; 9():178. PubMed ID: 20609221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
    Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
    Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.
    Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation.
    Kooijman R; Coppens A; Van den Keybus C
    Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression.
    Thompson C; Cloutier A; Bossé Y; Thivierge M; Gouill CL; Larivée P; McDonald PP; Stankova J; Rola-Pleszczynski M
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):697-704. PubMed ID: 16809637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression.
    Mayo MW; Steelman LS; McCubrey JA
    Oncogene; 1994 Jul; 9(7):1999-2008. PubMed ID: 8208545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
    Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
    Sng JC; Taniura H; Yoneda Y
    Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.